Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: results of the ATLANTIC study

被引：0

作者：

Storms, G. ^{[1
]}

Colin, I. ^{[2
]}

Veneman, T. ^{[3
]}

Mathieu, C. ^{[4
]}

机构：

[1] St Antonius Hosp, Utrecht, Netherlands

[2] CHR Clin St Joseph, Mons, Belgium

[3] Twenteborg Hosp, Almelo, Netherlands

[4] Katholieke Univ Leuven, Louvain, Belgium

来源：

DIABETOLOGIA | 2010年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

962

引用

页数：1

共 50 条

[1] SWITCHING FROM PREMIXED INSULIN TO BASAL-BOLUS INSULIN GLARGINE PLUS RAPID-ACTING INSULIN: THE ATLANTIC STUDY
Mathieu, C.
Storms, F.
Tits, J.
Veneman, T. F.
Colin, I. M.
[J]. ACTA CLINICA BELGICA, 2013, 68 (01): : 28 - 33
[2] Efficacy and Safety in Patients Switched to an Insulin Glargine Plus Rapid-Acting Analog Basal-Bolus Regimen: The GLAD Study
Oroszlan, Tamas
[J]. DIABETES, 2011, 60 : A604 - A605
[3] RAPID-ACTING INSULIN ANALOGUES IN BASAL-BOLUS REGIMENS IN TYPE 1 DIABETES MELLITUS
Garg, Satish
Javier Ampudia-Blasco, Francisco
Pfohl, Martin
[J]. ENDOCRINE PRACTICE, 2010, 16 (03) : 486 - 505
[4] Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study
Yenigun, M.
Honka, M.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (03) : 425 - 432
[5] Switching from an NPH Insulin to an Insulin Glargine Basal-Bolus Regimen Improves Glycemic Control in Diabetic Patients: The LINDA Study
Kvapil, Milan
Krivska, Bohumila
Avy, Zdenek Ru
[J]. DIABETES, 2011, 60 : A621 - A621
[6] INPATIENTS HYPERGLYCAEMIC CONTROL BY BASAL/BOLUS RAPID-ACTING INSULIN INJECTION
Bellido, I.
Vazquez-Marquez, M.
Gomez-Huelgas, R.
Lopez-Carmona, M.
Jansen, S.
Sobrino, B.
Chaves, M.
Martin-Gallardo, P.
Garcia-Fernandez, C.
Bernal-Lopez, M.
Blanco, E.
Garcia-Arnes, J.
Marquez, E.
de Pablo, J.
Gomez-Luque, A.
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 243 - 243
[7] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
Urakami, Tatsuhiko
Habu, Masako
Okuno, Misako
Suzuki, Junichi
Takahashi, Shori
[J]. DIABETES, 2014, 63 : A323 - A323
[8] Improvement in the glycaemic control of patients after switching from human insulin to insulin glargine-based basal-bolus regimen
Nagy Erzsebet
Kovacs Gabor
[J]. ORVOSI HETILAP, 2018, 159 (29) : 1201 - 1207
[9] Comparison of insulin glargine versus NPH insulin in people with type 2 diabetes mellitus under outpatient-clinic conditions for 18 months using a basal-bolus regimen with a rapid-acting insulin analogue as mealtime insulin
Siegmund, T.
Weber, S.
Blankenfeld, H.
Oeffner, A.
Schumm-Draeger, P.-M.
[J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (06) : 349 - 353
[10] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Riccardo Candido
Kathleen Wyne
Ester Romoli
[J]. Diabetes Therapy, 2018, 9 : 927 - 949

← 1 2 3 4 5 →